Loss of Response and Ustekinumab Dose Escalation in IBD Loss of Response and Ustekinumab Dose Escalation in IBD
Can dose escalation improve response to ustekinumab over time in patients with inflammatory bowel diseases?Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news